SVRA
Savara Inc
NASDAQ · Healthcare · Biotechnology · US
$4.60
−3.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 99.83x
- P/S forward
- 21.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.58x
- Price / sales
- —
- Price / cash flow
- -8.56x
Enterprise value
- Enterprise value
- $802.3M
- EV / sales
- —
- EV / EBITDA
- -5.77x
- EV / EBIT
- -5.59x
- Market cap
- $945.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026